Heck, they haven't even started testing mRNA vaccines for cancer treatment on humans yet.
Yes, they have. BNTX/RHHBY has two randomised PhII trials (advanced melanoma and ctDNA+ CRC after SOC) ongoing, while for MRNA/MRK it is one (high-risk melanoma). Also, BNTX has another six PhI's ongoing (one partnered with RHHBY), and for MRNA/MRK they are running two.
So you asserting with great certainty that mRNA will overtake DCVAX soon is not based on any evidential study.
These mRNA vaccines are being tested in a wide range of types, while neither -L or Direct is in any trial.
Market Data 
Markets 
